Asuragen - PDFSEARCH.IO - Document Search Engine

Asuragen
Results: 19

#	Item
11	Exhibits: February 16-18, 2015 ~ HALL D’ x 10’) Booths ~ 7 (10’ x 20’) Booths Floor Plan subject to change. Shaded booths reserved for sponsors. COMPANY Add to Reading List Source URL: www.giievent.tw Language: English* - Date: 2014-10-07 22:56:31 Asuragen Economy of Germany Pharmaceutical sciences Clinical research Analytik Jena Jena BioTek
12	Members Newsletter The Personalized Medicine Coalition, representing a broad spectrum of academic, industrial, patient, provider and payer communities, seeks to advance the understanding and adoption of personalized medi Add to Reading List Source URL: www.personalizedmedicinecoalition.org Language: English - Date: 2014-04-03 23:53:09 Health Genomics Evidence-based medicine Personalized medicine Navigenics Asuragen Pathway Genomics Biomarker Rosetta Genomics Medicine Biology Pharmacology
13	Next Generation Sequencing ACCURATE DETECTION OF CLINICALLY ACTIONABLE MUTATIONS DISCOVER • DEVELOP • DIAGNOSE Targeted FFPE Sequencing to Identify Novel, Disease-Related Mutations Add to Reading List Source URL: asuragen.com Language: English - Date: 2013-10-08 13:04:35 Biotechnology Pharmacology Asuragen KRAS BRAF Biomarker AKT1 HRAS Ras subfamily Medicine Biology Oncogenes
14	Members Newsletter The Personalized Medicine Coalition is an education and advocacy organization that promotes personalized medicine concepts and products for the benefit of patients. Our members include patient, payer, Add to Reading List Source URL: www.personalizedmedicinecoalition.org Language: English - Date: 2014-04-03 23:55:52 Genetics Pharmacology Evidence-based medicine Personalized medicine Dietrich Stephan Pathway Genomics Comparative effectiveness research Navigenics Asuragen Medicine Biology Genomics
15	GENOMICS services Tumor Bank Asuragen’s Tumor Bank Add to Reading List Source URL: asuragen.com Language: English - Date: 2013-10-08 13:04:35 Biochemistry Chemistry Laboratory techniques Polymerase chain reaction Hoffmann-La Roche BRAF Cancer research Melanoma Biology Molecular biology Biotechnology
16	Mirna Therapeutics Appoints Casi DeYoung as Chief Business Officer Austin, Texas – March 19, 2014 – Mirna Therapeutics (Mirna), a private, clinical stage biopharmaceutical company focused on the development of microR Add to Reading List Source URL: mirnarx.com Language: English - Date: 2014-04-02 16:53:00 Asuragen MicroRNA RNA Reata Pharmaceuticals
17	CHANGEAGENT PERSONALIZED MEDICINE COALITION ANNUAL REPORT 2012 The power in tailored therapeutics is for us to say more clearly to payers, providers, and patients—‘this drug is not Add to Reading List Source URL: www.personalizedmedicinecoalition.org Language: English - Date: 2014-04-22 15:28:39 Medicine Health Genetics Personalized medicine Asuragen Dietrich Stephan Theranostics Gualberto Ruaño Ralph Snyderman Genomics Pharmacology Biology
18	Exhibits: February 16-18, 2015 ~ HALL D[removed]’ x 10’) Booths ~ 7 (10’ x 20’) Booths Add to Reading List Source URL: www.triconference.com Language: English - Date: 2014-05-27 10:34:57 BioTek Geneious Almac Technology Science Biomatters PerkinElmer Asuragen
19	SECURITIES AND EXCHANGE COMMISSION FORM 8-K Add to Reading List Source URL: pdf.secdatabase.com Language: English - Date: 2012-06-03 08:54:50 Asuragen United States securities law Norwalk Connecticut Information Small interfering RNA Copyright Securities Act Business Technology Applied Biosystems Applera Celera Corporation